Researchers create patient‑specific stem cells via nuclear transfer, raising safety questions

Researchers create patient‑specific stem cells via nuclear transfer, raising safety questions The passage discusses scientific advances in stem‑cell technology and mentions researchers and institutions, but it does not link any high‑ranking officials, government agencies, or financial transactions to misconduct. The lead is of low investigative value beyond standard scientific reporting. Key insights: Induced pluripotent stem cells (iPS) were created by nuclear transfer of a donor's skin cell nucleus.; The resulting cells match the donor's nuclear DNA and may evade immune rejection.; Researchers claim no gross chromosomal abnormalities and comparable differentiation potential to traditional embryonic stem cells.